DrugCite
Search

FORASEQ

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Foraseq Adverse Events Reported to the FDA Over Time

How are Foraseq adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Foraseq, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Foraseq is flagged as the suspect drug causing the adverse event.

Most Common Foraseq Adverse Events Reported to the FDA

What are the most common Foraseq adverse events reported to the FDA?

Dyspnoea
438 (5.41%)
Death
228 (2.82%)
Cough
169 (2.09%)
Asthma
157 (1.94%)
Device Malfunction
153 (1.89%)
Fatigue
147 (1.82%)
Treatment Noncompliance
134 (1.66%)
Pneumonia
126 (1.56%)
Drug Ineffective
118 (1.46%)
Malaise
113 (1.4%)
Feeling Abnormal
101 (1.25%)
Show More Show More
Weight Decreased
96 (1.19%)
Oedema Peripheral
90 (1.11%)
Asthenia
87 (1.08%)
Nasopharyngitis
86 (1.06%)
Chest Pain
85 (1.05%)
Heart Rate Increased
76 (.94%)
Hypertension
76 (.94%)
Lung Disorder
74 (.91%)
Weight Increased
71 (.88%)
Vomiting
69 (.85%)
Influenza
67 (.83%)
Blood Pressure Increased
66 (.82%)
Incorrect Dose Administered
66 (.82%)
Bronchitis
65 (.8%)
Palpitations
61 (.75%)
Cardiac Disorder
60 (.74%)
Confusional State
60 (.74%)
Tremor
60 (.74%)
Dysphonia
59 (.73%)
Arrhythmia
57 (.7%)
Surgery
56 (.69%)
Emphysema
55 (.68%)
Nervousness
51 (.63%)
Pain
50 (.62%)
Condition Aggravated
44 (.54%)
Somnolence
44 (.54%)
Fall
42 (.52%)
Hypoaesthesia Oral
41 (.51%)
Dizziness
40 (.49%)
Gait Disturbance
40 (.49%)
Headache
40 (.49%)
Wheezing
40 (.49%)
Pulmonary Function Test Decreased
39 (.48%)
Abdominal Discomfort
38 (.47%)
Depression
38 (.47%)
Blood Pressure Fluctuation
37 (.46%)
Chronic Obstructive Pulmonary Disea...
37 (.46%)
Drug Exposure During Pregnancy
37 (.46%)
Abdominal Pain Upper
35 (.43%)
Cardiovascular Disorder
35 (.43%)
Pruritus
35 (.43%)
Electrocardiogram Abnormal
34 (.42%)
Product Quality Issue
34 (.42%)
Paraesthesia
33 (.41%)
Swelling
33 (.41%)
Drug Dose Omission
32 (.4%)
Pyrexia
32 (.4%)
Respiratory Failure
32 (.4%)
Tachycardia
32 (.4%)
Drug Administration Error
31 (.38%)
Insomnia
31 (.38%)
Syncope
31 (.38%)
Hypersensitivity
29 (.36%)
Cardiomegaly
28 (.35%)
Pain In Extremity
28 (.35%)
Toothache
28 (.35%)
Pleural Effusion
27 (.33%)
Bedridden
25 (.31%)
Cerebrovascular Accident
25 (.31%)
Dry Mouth
25 (.31%)
Cataract
24 (.3%)
Diabetes Mellitus
24 (.3%)
Lung Neoplasm Malignant
24 (.3%)
Wrong Technique In Drug Usage Proce...
24 (.3%)
Bronchospasm
23 (.28%)
Caesarean Section
23 (.28%)
Cardiac Arrest
23 (.28%)
Abasia
22 (.27%)
Back Pain
22 (.27%)
Lung Infection
22 (.27%)
Incorrect Route Of Drug Administrat...
21 (.26%)
Nausea
21 (.26%)
Respiratory Arrest
21 (.26%)
Anxiety
20 (.25%)
Eye Disorder
20 (.25%)
Throat Irritation
20 (.25%)
Thrombosis
20 (.25%)
Cardiac Failure
19 (.23%)
Normal Newborn
19 (.23%)
Pulmonary Oedema
19 (.23%)
Respiratory Disorder
19 (.23%)
Haemoptysis
18 (.22%)
Speech Disorder
18 (.22%)
Visual Acuity Reduced
18 (.22%)
Blood Glucose Increased
17 (.21%)
Cataract Operation
17 (.21%)
Generalised Oedema
17 (.21%)
Infarction
17 (.21%)
Infection
17 (.21%)
Burning Sensation
16 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Foraseq, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Foraseq is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Foraseq

What are the most common Foraseq adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Foraseq, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Foraseq is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Foraseq According to Those Reporting Adverse Events

Why are people taking Foraseq, according to those reporting adverse events to the FDA?

Asthma
333
Emphysema
135
Bronchitis
115
Dyspnoea
90
Chronic Obstructive Pulmonary Disea...
69
Lung Disorder
36
Show More Show More
Bronchitis Chronic
19
Cough
19
Respiratory Disorder
15
Fatigue
10
Pneumonia
10
Drug Use For Unknown Indication
8
Respiratory Failure
6
Bronchopneumonia
6
Allergic Bronchitis
6
Influenza
5
Bronchial Disorder
5
Pulmonary Fibrosis
4
Bronchospasm
4
Lung Neoplasm Malignant
4
Bronchiectasis
4
Wheezing
3
Hypersensitivity
3
Malaise
3
Bronchiolitis
3
Pruritus
3
Cystic Fibrosis
3
Increased Upper Airway Secretion
2
Sneezing
2
Traumatic Lung Injury
2
Cardiac Failure
2
Nasal Discomfort
2
Pulmonary Oedema
2
Collapse Of Lung
2
Pyothorax
2
Lung Infection
2
Rhinorrhoea
2
Chest Pain
2
Product Used For Unknown Indication
2
Pneumonitis
2
House Dust Allergy
2
Rhinitis
1
Hypoxia
1
Pneumothorax
1
Gastrooesophageal Reflux Disease
1
Obstructive Airways Disorder
1
Rhinitis Allergic
1
Nervousness
1
Nasopharyngitis
1
Postoperative Care
1
Embolism Arterial
1

Foraseq Case Reports

What Foraseq safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Foraseq. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Foraseq.